Vaxart
VXRT
VXRT was delisted on the 7th of July, 2025.
21 hedge funds and large institutions have $919K invested in Vaxart in 2018 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 4 closing their positions.
0% more funds holding
Funds holding: 21 → 21 (0)
0% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 4
2.34% less ownership
Funds ownership: 9.22% → 6.88% (-2.3%)
25% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 4
51% less capital invested
Capital invested by funds: $1.88M → $919K (-$958K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$111K |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
+$52.4K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$26.8K |
| 4 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$7.86K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$744 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$428K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$143K |
| 3 |
GCIA
Gabelli & Co Investment Advisers
Rye,
New York
|
-$54K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$36K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$11K |
VXRT Hedge Fund Activity: Q4 2018 in Review
21 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Vaxart (VXRT) for Q4 2018, worth a combined $919K — down 51% from $1.88M a quarter earlier.
Fund positioning in VXRT was balanced in Q4 2018: 4 funds opened new positions, 4 closed out, 3 added to existing stakes and 4 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $111K. The largest seller was Armistice Capital, exiting entirely with an estimated $428K sold.
- 21 institutional investors held Vaxart (VXRT) as of Q4 2018, unchanged from Q3 2018.
- Funds reported $919K of Vaxart stock for Q4 2018, down 51% quarter-over-quarter.
- 4 funds opened new Vaxart positions in Q4 2018 and 4 closed out, a net change of 0 holders.
- The largest Vaxart buyer in Q4 2018 was Renaissance Technologies, an estimated $111K added.
- The largest Vaxart seller in Q4 2018 was Armistice Capital, an estimated $428K sold.
Based on aggregated 13F filings for Q4 2018.